PYLCLARI

This brand name is authorized in Croatia, France, Ireland, Italy, Lithuania.

Active ingredients

The drug PYLCLARI contains one active pharmaceutical ingredient (API):

1
UNII 3934EF02T7 - PIFLUFOLASTAT F-18
 

Piflufolastat (18F) is a selective secondgeneration fluorine-18-labeled small-molecule PSMA inhibitor. Based on the intensity of the signals, PET images obtained using piflufolastat (18F) indicate the presence of PSMA expressing tissues.
 
Read more about Piflufolastat ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 PYLCLARI Solution for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V09IX16 V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 63404771, 68920959
IT Agenzia del Farmaco 050776018, 050776020
LT Valstybinė vaistų kontrolės tarnyba 1097413, 1097414

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈